Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Brand-name drug

Wixela price, strengths & recalls

Brand of fluticasone / salmeterol (generic)

Pharmacies pay $60.74 for 60 powders of Wixela 0.1 mg/actuation / 0.05 mg/actuation, 60 actuation inhaler (dry powder) this week, and from $60.74 to $97.48 across its 3 priced strengths and forms. The generic, fluticasone / salmeterol, costs pharmacies from $60.74. It is in shortage (being discontinued). It has 1 recall on record, none ongoing. Its official label last changed on September 12, 2022.

Being discontinuedBrand
Pharmacies pay$60.74for 60 powders of 0.1 mg/actuation / 0.05 mg/actuation, 60 actuation inhaler (dry powder)-5.7% in 4 weeks
Fair cash price
$80.35
Strengths
3
Makers
1
Updated
Nov 11

Wixela price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for the usual package. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
0.1 mg/actuation / 0.05 mg/actuation, 60 actuation inhaler (dry powder) Brand$1.01$60.74 / 60 powders-5.7%-12.4%
0.25 mg/actuation / 0.05 mg/actuation, 60 actuation inhaler (dry powder) Brand$1.21$72.47 / 60 powders-3.0%-11.0%
0.5 mg/actuation / 0.05 mg/actuation, 60 actuation inhaler (dry powder) Brand$1.62$97.48 / 60 powders-0.7%-6.5%

Wixela vs generic fluticasone / salmeterol

Generics have the same active ingredient, strength and form, and FDA requires them to work the same way. What pharmacies pay for each, same quantity:

StrengthBrandGenericBrand costs
0.1 mg/actuation / 0.05 mg/actuation, 60 actuation inhaler (dry powder)$60.74$60.74-
0.25 mg/actuation / 0.05 mg/actuation, 60 actuation inhaler (dry powder)$72.47$72.47-
0.5 mg/actuation / 0.05 mg/actuation, 60 actuation inhaler (dry powder)$97.48$97.48-
GenericFluticasone / salmeterol prices

Supply status: shortages & recalls

In shortage3 products are short or being discontinued
No ongoing recalls1 recall on record, latest Jan 3, 2024

Shortages

  • Advair HFA, Aerosol, Metered, 45 ug; 21 ug (NDC 0173-0715-22)GlaxoSmithKline · Being discontinued Jul 27, 2026 · Updated Jul 27, 2026The anticipated date that GSK will cease distribution of the presentation is approximately December 31, 2026. The 120 dose presentation of this product will still be available.
  • Advair HFA, Aerosol, Metered, 230 ug; 21 ug (NDC 0173-0717-22)GlaxoSmithKline · Being discontinued Jul 27, 2026 · Updated Jul 27, 2026The anticipated date that GSK will cease distribution of the presentation is approximately December 31, 2026. The 120 dose presentation of this product will still be available.
  • Advair HFA, Aerosol, Metered, 115 ug; 21 ug (NDC 0173-0716-22)GlaxoSmithKline · Being discontinued Jul 27, 2026 · Updated Jul 27, 2026The anticipated date that GSK will cease distribution of the presentation is approximately December 31, 2026. The 120 dose presentation of this product will still be available.

In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.

Recalls

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

What did you pay for wixela? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedSeptember 12, 2022
Version6 of 6
EffectiveAug 29, 2022
Read the label

These highlights do not include all the information needed to use WIXELA INHUB® safely and effectively. See full prescribing information for WIXELA INHUB®. WIXELA INHUB® (fluticasone propionate and salmeterol inhalation powder), for oral inhalation useInitial U.S. Approval: 2000

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Generic makers
4 approved generic applications on the market

Wixela questions

How much does wixela cost without insurance?

Pharmacies pay about $60.74 for 60 powders of wixela 0.1 mg/actuation / 0.05 mg/actuation, 60 actuation inhaler (dry powder) ($1.01 per unit). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $80.35. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

Is there a generic for Wixela?

Yes: fluticasone / salmeterol. Pharmacies pay from $60.74 for it. Compare fluticasone / salmeterol prices.

Is wixela in shortage?

Yes. 3 products are listed as in shortage or being discontinued (being discontinued). See which ones.

Has wixela been recalled?

1 recall on record, none ongoing. Recalls name specific lots - check yours.

When did the wixela label last change?

The official label was last updated on September 12, 2022 (version 6). See what changed.

Talk about wixela

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.